Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 9153403, 13 pages
https://doi.org/10.1155/2017/9153403
Research Article

Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a′]diisoquinoline Derivative and Its Synergistic Action with Nigella sativa in Human Gastric Cancer Cells

1Department of Biotechnology, Medical University of Białystok, Kilinskiego 1, 15-089 Białystok, Poland
2Department of Synthesis and Technology of Drugs, Medical University of Białystok, Kilinskiego 1, 15-089 Białystok, Poland
3Herbarium of Department of Pharmacognosy, Medical University of Białystok, Kilinskiego 1, 15-089 Białystok, Poland

Correspondence should be addressed to Agnieszka Gornowicz; lp.ude.bmu@zciwonrog.akzseinga

Received 4 August 2017; Revised 9 November 2017; Accepted 27 November 2017; Published 26 December 2017

Academic Editor: Anne Hamburger

Copyright © 2017 Anna Czajkowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Fontana and E. C. Smyth, “Novel targets in the treatment of advanced gastric cancer: a perspective review,” Therapeutic Advances in Medical Oncology, vol. 8, no. 2, pp. 113–125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Koizumi, “Chemotherapy for advanced gastric cancer: review of global and japanese status,” Gastrointestinal Cancer Research, vol. 1, no. 5, pp. 197–203, 2007. View at Google Scholar
  3. E. L. Baldwin and N. Osheroff, “Etoposide, topoisomerase II and cancer,” Current Medicinal Chemistry - Anti-Cancer Agents, vol. 5, no. 4, pp. 363–372, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Zali, M. Zamanian-Azodi, M. A. Shokrgozar, and M. Rezaei-Tavirani, “Cytotoxic effects of human calprotectin on gastric cancer cell line is attenuated by etoposide,” Gastroenterology and Hepatology from Bed to Bench, vol. 5, no. 3, pp. 132–138, 2012. View at Google Scholar · View at Scopus
  5. J. H. Chung, Y. Z. Bae, S. H. Kim et al., “Salvage treatment for advanced gastric cancer using fep (5-fu, etoposide, cisplatin) combination chemotherapy,” Cancer Research and Treatment, vol. 34, no. 5, pp. 382–387, 2002. View at Publisher · View at Google Scholar
  6. K. Nishikawa, K. Fujitani, H. Inagaki et al., “Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial,” European Journal of Cancer, vol. 51, no. 7, pp. 808–816, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. B. H. Ali and G. Blunden, “Pharmacological and toxicological properties of Nigella sativa,” Phytotherapy Research, vol. 17, no. 4, pp. 299–305, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Lepiarczyk, Z. Kałuza, A. Bielawska, R. Czarnomysy, A. Gornowicz, and K. Bielawski, “Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a]diisoquinoline derivatives in human breast cancer cells,” Archives of Pharmacal Research, vol. 38, no. 5, pp. 628–641, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gornowicz, N. Pawłowska, A. Czajkowska et al., “Biological evaluation of octahydropyrazin[2,1-a:5,4-a]diisoquinoline derivatives as potent anticancer agents,” Tumor Biology, vol. 39, no. 6, 2017. View at Publisher · View at Google Scholar
  10. Z. Kałuza, D. Mostowicz, G. Dołȩga, K. Mroczko, and R. Wójcik, “10b-Substituted hexahydropyrrolo-isoquinolines: Studies on diastereoselective formation of a quaternary carbon stereocenter via N-acyliminium ion cyclization,” Tetrahedron, vol. 62, no. 5, pp. 943–953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Kałuza, D. Mostowicz, G. Dołega, and R. Wójcik, “A new route to optically pure highly functionalized tetrahydro-isoquinolines with a quaternary carbon stereocenter,” Tetrahedron, vol. 64, no. 10, pp. 2321–2328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Kałuza, K. Bielawski, R. Ćwiek, P. Niedziejko, and P. Kaliski, “C2-Symmetric hemiaminal ethers and diamines: New ligands for copper-catalyzed desymmetrization of meso-1,2-diols and asymmetric Henry reactions,” Tetrahedron: Asymmetry, vol. 24, no. 21-22, pp. 1435–1442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Carmichael, W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell, “Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity,” Cancer Research, vol. 47, no. 4, pp. 943–946, 1987. View at Google Scholar · View at Scopus
  14. H. N. López-Basave, F. Morales-Vásquez, J. M. Ruiz-Molina et al., “Gastric cancer in young people under 30 years of age: Worse prognosis, or delay in diagnosis?” Cancer Management and Research, vol. 5, no. 1, pp. 31–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Darakhshan, A. Bidmeshki Pour, A. Hosseinzadeh Colagar, and S. Sisakhtnezhad, “Thymoquinone and its therapeutic potentials,” Pharmacological Research, vol. 95-96, pp. 138–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Khan, H.-C. Chen, M. Tania, and D.-Z. Zhang, “Anticancer activities of Nigella sativa (black cumin),” African Journal of Traditional, Complementary and Alternative Medicines, vol. 8, supplement 5, pp. 226–232, 2011. View at Google Scholar · View at Scopus
  17. H. Gali-Muhtasib, M. Diab-Assaf, C. Boltze et al., “Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.,” International Journal of Oncology, vol. 25, no. 4, pp. 857–866, 2004. View at Google Scholar · View at Scopus
  18. F. Wilson-Simpson, S. Vance, and H. Benghuzzi, “Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE),” Biomedical Sciences Instrumentation, vol. 43, pp. 378–383, 2007. View at Google Scholar · View at Scopus
  19. I. O. Racoma, W. H. Meisen, Q.-E. Wang, B. Kaur, and A. A. Wani, “Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells,” PLOS ONE, vol. 8, no. 9, Article ID e72882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. M. Awad, “In vitro decreases of the fibrinolytic potential of cultured human fibrosarcoma cell line, HT1080, by Nigella sativa oil,” Phytomedicine, vol. 12, no. 1-2, pp. 100–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Roepke, A. Diestel, K. Bajbouj et al., “Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells,” Cancer Biology & Therapy, vol. 6, no. 2, pp. 160–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-C. Chu, Y.-S. Hsieh, C.-C. Yu, Y.-Y. Lai, and P.-N. Chen, “Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy,” PLOS ONE, vol. 9, no. 7, Article ID e101579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Rooney and M. F. Ryan, “Effects of alpha-hederin and thymoquinone, constituents of Nigella sativa, on human cancer cell lines,” Anticancer Reseach, vol. 25, no. 3 B, pp. 2199–2204, 2005. View at Google Scholar · View at Scopus
  24. S. M. K. Swamy and B. T. K. Huat, “Intracellular glutathione depletion and reactive oxygen species generation are important in α-hederin-induced apoptosis of P388 cells,” Molecular and Cellular Biochemistry, vol. 245, no. 1-2, pp. 127–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. I. O. Farah and R. A. Begum, “Effect of Nigella sativa (N. Sativa L.) and oxidative stress on the survival pattern of MCF-7 breast cancer cells,” Biomedical Sciences Instrumentation, vol. 39, pp. 359–364, 2003. View at Google Scholar · View at Scopus
  26. M. I. Thabrew, R. R. Mitry, M. A. Morsy, and R. D. Hughes, “Cytotoxic effects of a decoction of Nigella sativa, Hemidesmus indicus and Smilax glabra on human hepatoma HepG2 cells,” Life Sciences, vol. 77, no. 12, pp. 1319–1330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. A. Abd El-Aziz, H. A. Hassan, M. H. Mohamed, A.-R. M. A. Meki, S. K. H. Abdel-Ghaffar, and M. R. Hussein, “The biochemical and morphological alterations following administration of melatonin, retinoic acid and Nigella sativa in mammary carcinoma: An animal model,” International Journal of Clinical and Experimental Pathology, vol. 86, no. 6, pp. 383–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. E. I. Salim and S. Fukushima, “Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis,” Nutrition and Cancer, vol. 45, no. 2, pp. 195–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. E. S. Al-Sheddi, N. N. Farshori, M. M. Al-Oqail, J. Musarrat, A. A. Al-Khedhairy, and M. A. Siddiqui, “Cytotoxicity of Nigella Sativa seed oil and extract against human lung cancer cell line,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 2, pp. 983–987, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Khan and S. Sultana, “Inhibition of two stage renal carcinogenesis, oxidative damage and hyperproliterative response by Nigella sativa,” European Journal of Cancer Prevention, vol. 14, no. 2, pp. 159–168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. G. M. Mabrouk, S. S. Moselhy, S. F. Zohny et al., “Inhibition of methylnitrosourea (MNU) induced oxidative stress and carcinogenesis by orally administered bee honey and nigella grains in sprague dawely rats,” Journal of Experimental & Clinical Cancer Research, vol. 21, no. 3, pp. 341–346, 2002. View at Google Scholar · View at Scopus
  32. X. Lei, X. Lv, M. Liu et al., “Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 417, no. 2, pp. 864–868, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. R. Khalife, E.-H. Stephany, O. Tarras, M. H. Hodroj, and S. Rizk, “Antiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemia,” Clinical Lymphoma, Myeloma & Leukemia, vol. 14, pp. S46–S55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Khalife, M. H. Hodroj, R. Fakhoury, and S. Rizk, “Thymoquinone from nigella sativa seeds promotes the antitumor activity of noncytotoxic doses of topotecan in human colorectal cancer cells in vitro,” Planta Medica, vol. 82, no. 4, pp. 312–321, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Banerjee, A. O. Kaseb, Z. Wang et al., “Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer,” Cancer Research, vol. 69, pp. 5575–5583, 2009. View at Publisher · View at Google Scholar
  36. A. Dirican, H. Atmaca, E. Bozkurt, C. Erten, B. Karaca, and R. Uslu, “Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway,” Clinical and Translational Oncology, vol. 17, no. 2, pp. 145–151, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Ç. Şakalar, K. İzgi, B. İskender et al., “The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer,” Tumor Biology, vol. 37, no. 4, pp. 4467–4477, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ganji-Harsini, M. Khazaei, Z. Rashidi, and A. Ghanbari, “Thymoquinone could increase the efficacy of tamoxifen induced apoptosis in human breast cancer cells: an in vitro study,” Cell, vol. 18, no. 2, pp. 245–254, 2016. View at Google Scholar · View at Scopus
  39. P. Soni, J. Kaur, and K. Tikoo, “Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy,” Journal of Nanoparticle Research, vol. 17, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. E. M. Saleh, R. A. El-awady, N. A. Eissa, and W. M. Abdel-Rahman, “Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways,” Cancer Biology & Therapy, vol. 13, no. 11, pp. 1058–1071, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. E.-S. A. Arafa, Q. Zhu, Z. I. Shah et al., “Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells,” Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 706, no. 1-2, pp. 28–35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. R. L. Gurung, S. N. Lim, A. K. Khaw et al., “Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells,” PLOS ONE, vol. 5, no. 8, Article ID e12124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. S. H. Jafri, J. Glass, R. Shi, S. Zhang, M. Prince, and H. Kleiner-Hancock, “Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo,” Journal of Experimental & Clinical Cancer Research, vol. 29, no. 1, article no. 87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Banerjee, S. Padhye, A. Azmi et al., “Review on molecular and therapeutic potential of thymoquinone in cancer,” Nutrition and Cancer, vol. 62, no. 7, pp. 938–946, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. S. Mahmoud and V. P. Torchilin, “Hormetic/cytotoxic effects of nigella sativa seed alcoholic and aqueous extracts on mcf-7 breast cancer cells alone or in combination with doxorubicin,” Cell Biochemistry and Biophysics, vol. 66, no. 3, pp. 451–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Gornowicz, Z. Kałuza, A. Bielawska, H. Gabryel-Porowska, R. Czarnomysy, and K. Bielawski, “Cytotoxic efficacy of a novel dinuclear platinum(II) complex used with anti-MUC1 in human breast cancer cells,” Molecular and Cellular Biochemistry, vol. 392, no. 1-2, pp. 161–174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Gornowicz, A. Bielawska, R. Czarnomysy, H. Gabryel-Porowska, A. Muszyńska, and K. Bielawski, “The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells,” Molecular and Cellular Biochemistry, vol. 408, no. 1-2, pp. 103–113, 2015. View at Publisher · View at Google Scholar · View at Scopus